Search research articles
Contact Us
Filters
Showing results (1-10 of 80) with videos related to
Page
of 8
Sort By:
IUBMB Life
|
August 25, 2005
Liver stem cells
Vance B Matthews, George C Yeoh
Journal of Molecular Medicine (Berlin, Germany)
|
January 23, 2008
CNTF: a target therapeutic for obesity-related metabolic disease?
Vance B Matthews, Mark A Febbraio
Biochemistry and Biophysics Reports
|
August 28, 2018
A cautionary note for researchers treating mice with the neurotransmitter norepinephrine
Vance B Matthews, Caroline Rudnicka, Markus P Schlaich
Current Opinion in Nephrology and Hypertension
|
January 28, 2022
Interaction between sodium-glucose co-transporter 2 and the sympathetic nervous system
Omar Azzam, Vance B Matthews, Markus P Schlaich
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society
|
November 24, 2004
Direct effects of interleukin-6 on liver progenitor oval cells in culture
Vance B Matthews, Elizabeth Klinken, George C T Yeoh
Handbook of Experimental Pharmacology
|
April 13, 2011
Overcoming insulin resistance with ciliary neurotrophic factor
Tamara L Allen, Vance B Matthews, Mark A Febbraio
Nephrology (Carlton, Vic.)
|
December 2, 2011
Obesity-induced renal impairment is exacerbated in interleukin-6-knockout mice
Brooke E Harcourt, Josephine M Forbes, Vance B Matthews
Neural Regeneration Research
|
February 15, 2019
Sympathetic stimulation with norepinephrine may come at a cost
Lakshini Y Herat, Markus P Schlaich, Vance B Matthews
Hepatology (Baltimore, Md.)
|
September 7, 2004
Genetic manipulations utilizing albumin and alpha-fetoprotein promoter/enhancers affect both hepatocytes and oval cells
Vance B Matthews, Stefan Rose-John, George C T Yeoh
Cardiovascular Diagnosis and Therapy
|
March 19, 2019
Self-monitoring of blood pressure to guide titration of antihypertensive medication-a new era in hypertension management?
Jan K Ho, Revathy Carnagarin, Vance B Matthews, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 80) with videos related to
Sort By:
Page
of 8
IUBMB Life
|
August 25, 2005
Liver stem cells
Vance B Matthews, George C Yeoh
Journal of Molecular Medicine (Berlin, Germany)
|
January 23, 2008
CNTF: a target therapeutic for obesity-related metabolic disease?
Vance B Matthews, Mark A Febbraio
Biochemistry and Biophysics Reports
|
August 28, 2018
A cautionary note for researchers treating mice with the neurotransmitter norepinephrine
Vance B Matthews, Caroline Rudnicka, Markus P Schlaich
Current Opinion in Nephrology and Hypertension
|
January 28, 2022
Interaction between sodium-glucose co-transporter 2 and the sympathetic nervous system
Omar Azzam, Vance B Matthews, Markus P Schlaich
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society
|
November 24, 2004
Direct effects of interleukin-6 on liver progenitor oval cells in culture
Vance B Matthews, Elizabeth Klinken, George C T Yeoh
Handbook of Experimental Pharmacology
|
April 13, 2011
Overcoming insulin resistance with ciliary neurotrophic factor
Tamara L Allen, Vance B Matthews, Mark A Febbraio
Nephrology (Carlton, Vic.)
|
December 2, 2011
Obesity-induced renal impairment is exacerbated in interleukin-6-knockout mice
Brooke E Harcourt, Josephine M Forbes, Vance B Matthews
Neural Regeneration Research
|
February 15, 2019
Sympathetic stimulation with norepinephrine may come at a cost
Lakshini Y Herat, Markus P Schlaich, Vance B Matthews
Hepatology (Baltimore, Md.)
|
September 7, 2004
Genetic manipulations utilizing albumin and alpha-fetoprotein promoter/enhancers affect both hepatocytes and oval cells
Vance B Matthews, Stefan Rose-John, George C T Yeoh
Cardiovascular Diagnosis and Therapy
|
March 19, 2019
Self-monitoring of blood pressure to guide titration of antihypertensive medication-a new era in hypertension management?
Jan K Ho, Revathy Carnagarin, Vance B Matthews, et al.
Page
of 8